GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Clinical Laserthermia Systems AB (OSTO:CLS B) » Definitions » Debt-to-Equity

Clinical Laserthermia Systems AB (OSTO:CLS B) Debt-to-Equity : 0.01 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Clinical Laserthermia Systems AB Debt-to-Equity?

Clinical Laserthermia Systems AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr0.23 Mil. Clinical Laserthermia Systems AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr0.22 Mil. Clinical Laserthermia Systems AB's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr50.69 Mil. Clinical Laserthermia Systems AB's debt to equity for the quarter that ended in Mar. 2024 was 0.01.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Clinical Laserthermia Systems AB's Debt-to-Equity or its related term are showing as below:

OSTO:CLS B' s Debt-to-Equity Range Over the Past 10 Years
Min: 0   Med: 0.03   Max: 3.33
Current: 0.01

During the past 13 years, the highest Debt-to-Equity Ratio of Clinical Laserthermia Systems AB was 3.33. The lowest was 0.00. And the median was 0.03.

OSTO:CLS B's Debt-to-Equity is ranked better than
99.86% of 700 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs OSTO:CLS B: 0.01

Clinical Laserthermia Systems AB Debt-to-Equity Historical Data

The historical data trend for Clinical Laserthermia Systems AB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinical Laserthermia Systems AB Debt-to-Equity Chart

Clinical Laserthermia Systems AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.15 0.05 0.01 3.33

Clinical Laserthermia Systems AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.33 - - - 0.01

Competitive Comparison of Clinical Laserthermia Systems AB's Debt-to-Equity

For the Medical Devices subindustry, Clinical Laserthermia Systems AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clinical Laserthermia Systems AB's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Clinical Laserthermia Systems AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Clinical Laserthermia Systems AB's Debt-to-Equity falls into.



Clinical Laserthermia Systems AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Clinical Laserthermia Systems AB's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Clinical Laserthermia Systems AB's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clinical Laserthermia Systems AB  (OSTO:CLS B) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Clinical Laserthermia Systems AB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Clinical Laserthermia Systems AB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Clinical Laserthermia Systems AB (OSTO:CLS B) Business Description

Traded in Other Exchanges
Address
Scheelevagen 2, Medicon village, Lund, SWE, 223 81
Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.

Clinical Laserthermia Systems AB (OSTO:CLS B) Headlines

No Headlines